Evidence map›Paper›PMID 42352992›Full record

ArticleInternational journal of molecular sciences2026

Differential Radiomodulatory Effects of Sodium Aminodihydrophthalazinedione (Tameron

Artem Ermakov, Elena Tsarkova, Olga Ermakova, Olga Antonova, Olga Kochetkova, Danil Kolmanovich, Anastasia Kolotova, Edward Evdokimovskii, Artem Blagodatski, Anton Popov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Artem ErmakovInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0000-0001-7810-0675
Elena TsarkovaANO Engineering Physics Institute, Bolshoi Udarny Pereulok, 1A, Bldg. 1, Serpuhov 142210, Russia.
Olga ErmakovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.
Olga AntonovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0000-0003-3311-8745
Olga KochetkovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0000-0003-1758-907X
Danil KolmanovichInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0000-0003-3391-7889
Anastasia KolotovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0009-0005-8023-285X
Edward EvdokimovskiiInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.
Artem BlagodatskiInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.
Anton PopovInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 3 Institutskaya Str., Pushchino 142290, Russia.ORCID 0000-0003-2643-4846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is one of the most effective methods of cancer treatment. New, more effective, and safer radiotherapy methods can be developed thanks to selective radioprotectors. In our study, we investigated the antioxidant and radiomodulatory activity of sodium aminodihydrophthalazinedione (the drug Tameron

Indexed as

AntioxidantsDNA DamageOsteosarcomaRadiation-Protective AgentsTranscriptomeApoptosisCell Line, TumorDNA RepairGene Expression ProfilingHumansMesenchymal Stem CellsReactive Oxygen SpeciesX-RaysAntioxidantsRadiation-Protective AgentsReactive Oxygen SpeciesantioxidantDNA double-strand breaksluminolmesenchymal stem cellsnanopore sequencingosteosarcomaradioprotectionradiotherapyreactive oxygen speciesTamerontranscriptomics

Identifiers

PMID42352992
PMCPMC13299281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.